The Biggest Psychedelic News Stories of the Week – July 21 | Psychedelic Spotlight

This week, the psychedelic news-sphere has been abuzz with a few standout stories. From important policy updates to psychedelic IPOs, it’s clear that the field of psychedelics continues to grow and evolve at an exciting rate—so we’ve rounded up the top seven headlines here for your convenience.

Risk Adjusted Net Present Value: What is the current valuation of Zai Lab’s (Trospium chloride + Xanomeline)

The revenue for (Trospium chloride + Xanomeline) is expected to reach an annual total of $761 mn by 2033 globally based off GlobalData’s Expiry Model.

May 16, 2024

DDT exposure found to alter sperm epigenome in humans

In a study that signals potential reproductive and health complications in humans, now and for future generations, researchers from McGill University, the University of Pretoria,

February 9, 2024

Novo-Catalent deal likely to be one-off — with some caveats, insiders say

An acquisition similar to Novo Holdings’ proposed $16.5 billion buy for Catalent is unlikely to happen again because it bucks the trend of pharma companies

February 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.